SIRT-IN-5, a selective inhibitor of SIRT3 with an IC50 of 2.88 µM, facilitates the differentiation of multiple myeloma cells. This differentiation is associated with increased expression of the differentiation antigens CD49e and human immunoglobulin light chains lambda and kappa.
Target:
Sirtuin
* VAT and and shipping costs not included. Errors and price changes excepted
